GLP-1 receptor agonists affect multiple regions of the reward pathway that mediate addiction to foods and various other substances including alcohol, opioids, nicotine, and cocaine
Outpatient service location: a
These are prepared by specialized pharmacies and are often marketed as more affordable GLP-1 alternatives
A 2024 study suggests injectable semaglutide leads to more weight loss in real-world settings
Short for glucagon-like peptide-1 (but who has time for that mouthful?), this gut-derived incretin is a big-time player in metabolism, appetite, and blood sugar regulation
Reported complications in GLP-1 lawsuits include gastroparesis, bowel obstruction, ileus, cyclic vomiting syndrome, gallbladder disease, pulmonary aspiration during surgery, and non-arteritic anterior ischemic optic neuropathy (NAION), a rare optic nerve injury associated with sudden and potentially permanent vision loss